Skip to main content
INVION LIMITED logo

INVION LIMITED — Investor Relations & Filings

Ticker · IVX ISIN · AU000000IVX4 LEI · 529900JY0HVEQEMSSJ32 ASX Professional, scientific and technical activities
Filings indexed 1,119 across all filing types
Latest filing 2014-11-09 Capital/Financing Update
Country AU Australia
Listing ASX IVX

About INVION LIMITED

https://inviongroup.com

Invion Limited is a life sciences company dedicated to the development and commercialization of Photosoft technology, a next-generation Photodynamic Therapy (PDT). The company focuses on utilizing this light-activated treatment platform to target various forms of cancer and infectious diseases. Photosoft technology is derived from natural chlorophyll and is designed to selectively destroy malignant cells while minimizing damage to healthy tissue. Invion's research and development efforts are primarily directed toward oncology applications, including the treatment of skin, lung, and ovarian cancers, as well as addressing global health challenges through the treatment of viral and bacterial infections. The company aims to provide non-invasive or minimally invasive therapeutic alternatives that offer improved patient outcomes and reduced side effects compared to conventional treatment modalities.

Recent filings

Filing Released Lang Actions
Funding Agreement with Australian Special Opportunity Fund 2 pages 272.0KB
Capital/Financing Update Classification · 100% confidence The document is an ASX media announcement dated 10 November 2014, detailing an investment agreement between Invion Limited and the Australian Special Opportunity Fund. It describes the terms of the funding commitment, including convertible securities, equity purchases, options, and shareholder approval requirements. The content focuses on financing activities and capital structure changes, with no financial statements or quarterly results presented. The document length is 7180 characters, which is sufficient for a detailed announcement but does not constitute a full financial report. Therefore, this document is best classified as a Capital/Financing Update (CAP).
2014-11-09 English
Appendix 3B 13 pages 506.7KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B' and is an announcement related to the issuance of new securities, including fully paid ordinary shares and share options. It includes detailed information about the class, number, terms, issue price, purpose of the issue, and compliance with ASX listing rules. The document is a formal notification to the Australian Securities Exchange (ASX) about a capital raising event and the application for quotation of additional securities. It does not contain financial statements, management discussion, or audit information. It is not a report but an announcement of a capital/financing activity. Therefore, the appropriate classification is 'Capital/Financing Update' (CAP). The document length (15,000 characters) and content confirm it is a substantive announcement, not a brief notice or a report publication announcement.
2014-11-09 English
Notice under Section 708A 1 page 216.0KB
Share Issue/Capital Change Classification · 95% confidence The document is an ASX announcement titled 'Section 708A Notice' regarding the issue of shares and share options without disclosure under the Corporations Act 2001. It references compliance with specific sections of the Act and details the issuance of shares and options. The document is short (1192 characters) and serves as a regulatory notice about share issuance without disclosure, rather than a full financial report or detailed capital update. This fits the category of Share Issue/Capital Change announcements, which cover new share issues or capital changes. Therefore, the appropriate classification is SHA (Share Issue/Capital Change).
2014-11-09 English
Appendix 4C - quarterly 5 pages 332.6KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'APPENDIX 4C' and is an ASX announcement dated 31 October 2014, reporting quarterly cash flow and financial data for the quarter ending 30 September 2014. It includes detailed cash flow statements, payments to directors, financing facilities, and compliance statements. Appendix 4C is a known quarterly report format for entities admitted on the basis of commitments, typically used in Australian stock exchange filings to report quarterly cash flows and operational updates. The document contains actual financial data and analysis for a quarter, not just an announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2015
2014-10-30 English
Annual Report to shareholders 84 pages 8.9MB
Annual Report Classification · 100% confidence The document is titled 'INVION LIMITED ANNUAL REPORT 2014' and contains detailed company information including company profile, operations, drug development pipeline, milestones, a letter from the Chairman & CEO, and detailed descriptions of the board of directors. The content is comprehensive and covers the full fiscal year 2014, consistent with an official yearly report. There is no indication that this is merely an announcement or a summary; rather, it is the full annual report itself. The length of the document (15,000 characters) supports that it is a full report rather than a brief announcement. Therefore, the document fits the definition of an Annual Report (10-K). FY 2014
2014-10-30 English
AGM Notice of Meeting and Proxy Form 22 pages 1.0MB
AGM Information Classification · 95% confidence The document is titled 'NOTICE OF ANNUAL GENERAL MEETING AND EXPLANATORY MEMORANDUM' for Invion Limited, dated 20 October 2014. It includes details about the AGM date, location, agenda items such as receiving financial statements, directors' remuneration report, re-election of directors, and special business resolutions. The text explicitly states it is a Notice of Meeting and Explanatory Memorandum for the Annual General Meeting, inviting shareholders to attend and vote. It does not contain the actual financial statements or reports but refers to them being considered at the meeting. The document is about the meeting notice and explanatory materials, not the full annual report or financial statements themselves. Therefore, it fits the category of AGM Information (AGM-R). The document length is substantial (15,000 characters), consistent with detailed AGM notices and explanatory memoranda. Hence, the classification is AGM-R with high confidence.
2014-10-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.